Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

5.77
+0.09001.58%
Volume:312.15K
Turnover:1.79M
Market Cap:295.85M
PE:-1.70
High:5.84
Open:5.59
Low:5.51
Close:5.68
52wk High:14.06
52wk Low:4.36
Shares:51.27M
Float Shares:48.37M
Volume Ratio:1.81
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3870
EPS(LYR):0.9300
ROE:-40.29%
ROA:6.93%
PB:0.87
PE(LYR):6.20

Loading ...

BRIEF-Emergent Biosolutions Receives $64.5 Million Contract Modification For Bat® To Support U.S. Biodefense Strategy

Reuters
·
May 29

Emergent BioSolutions wins USD 64.5 million HHS contract modification for botulism antitoxin BAT

Reuters
·
May 29

Emergent BioSolutions Receives $64.5 Million Contract Modification for Bat® [Botulism Antitoxin Heptavalent (a, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy

THOMSON REUTERS
·
May 29

Emergent BioSolutions to present at Jefferies Global Healthcare Conference

Reuters
·
May 20

Saudi regulator SFDA approves Emergent ACAM2000 vaccine for smallpox, mpox prevention

Reuters
·
May 18

Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for Acam2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]

THOMSON REUTERS
·
May 18

Press Release: Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments

Dow Jones
·
May 08

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)

TIPRANKS
·
May 04

Emergent BioSolutions Earnings Call Highlights Turnaround Momentum

TIPRANKS
·
May 02

Emergent BioSolutions Posts Weak Q1 Results Amid Turnaround

TIPRANKS
·
May 01

Emergent BioSolutions Q1 Revenue USD 156.1 Million

Reuters
·
May 01

Emergent BioSolutions Q1 Adj. EPS $0.21 Beats $(0.25) Estimate, Sales $156.100M Beat $145.000M Estimate

Benzinga Earnings
·
May 01

Emergent BioSolutions Reports First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 01

Emergent BioSolutions Outlook FY Adjusted Net Income USD 45-65 Million

THOMSON REUTERS
·
May 01

Emergent BioSolutions Q1 Gross Margin 41%

THOMSON REUTERS
·
May 01

Emergent BioSolutions receives Singapore regulatory approval for ACAM2000

TIPRANKS
·
Apr 30

BRIEF-Emergent Biosolutions Receives Approval From Singapore Health Sciences Authority

Reuters
·
Apr 30

Singapore HSA approves Emergent ACAM2000 vaccine label expansion to include mpox

Reuters
·
Apr 30

Emergent BioSolutions shareholders approved amendment to increase stock incentive plan shares

Reuters
·
Apr 30

Emergent BioSolutions Inc: Executed Agreement Is Valued at Approximately $50 Mln

THOMSON REUTERS
·
Apr 29